Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 19:13:845051.
doi: 10.3389/fendo.2022.845051. eCollection 2022.

The Experience of Fertility Preservation in a Single Tertiary Center in Korea

Affiliations

The Experience of Fertility Preservation in a Single Tertiary Center in Korea

Yae Ji Choi et al. Front Endocrinol (Lausanne). .

Abstract

Objective: Oocyte (OC), embryo (EC), and ovarian tissue cryopreservation (OTC) are options for fertility preservation (FP) before going through gonadotoxic cancer treatment, or anticipated fertility decline in benign ovarian diseases, or for planned OC. The aim of this study is to report outcomes of FP in a single tertiary hospital in Korea.

Methods: This is a retrospective study of OC, EC, and OTC cycles. All patients who visited or were referred to the infertility clinic at the Department of Obstetrics and Gynecology for the purpose of FP between 2010 and October 2021 were included.

Results: A total of 564 controlled ovarian stimulation cycles were conducted in 416 women. Three hundred fifty-seven women underwent 494 OC cycles. Most patients were diagnosed with breast cancer (22.4%), followed by endometriomas (21.9%), and then by planned OC (20.7%). Cases of OC have increased over the years, peaking at 109 cycles in 2019 compared to one in 2010. Fifty-nine women underwent 70 EC cycles, and breast cancer (50.8%) was the most common indication. Repetitive OC and EC cycles were undergone in 92 and 9 women, respectively (mean number of repetition, 1.37 and 1.19 times in OC and EC, respectively), yielding a maximum number of 33 oocytes or 23 embryos being cryopreserved per patient. The utilization rate was 3.1% (11/357) in OC and 16.9% (10/59) in EC. Twenty-six women underwent OTC, and gynecologic cancer was the most common indication (9/26, 34.6%). One woman had the cryopreserved ovarian tissue retransplanted and successfully generated embryos.

Conclusion: OC, EC, and OTC are possible options for preserving fertility, and these opportunities should be provided for women at risk of fertility decline or those who are eager to protect their future fertility. This is the first report on long-term FP outcomes in a single tertiary center in Korea. We expect that there will be more cases over the years and more women returning to use their gametes or embryos for pregnancy.

Keywords: embryo cyropreservation; fertility preservation; oncofertility; oocyte cryopreservation; ovarian tissue cryopreservation.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The number of total oocyte cryopreservation, embryo cryopreservation cycles, and ovarian tissue cryopreservation by year. OC, oocyte cryopreservation; EC, embryo cryopreservation; OTC, ovarian tissue cryopreservation.

Similar articles

Cited by

References

    1. Meirow D, Nugent D. The Effects of Radiotherapy and Chemotherapy on Female Reproduction. Hum Reprod Update (2001) 7(6):535–43. doi: 10.1093/humupd/7.6.535 - DOI - PubMed
    1. Bedoschi GM, Navarro PA, Oktay KH. Novel Insights Into the Pathophysiology of Chemotherapy-Induced Damage to the Ovary. Panminerva Med (2019) 61(1):68–75. doi: 10.23736/S0031-0808.18.03494-8 - DOI - PubMed
    1. Lim JW. The Changing Trends in Live Birth Statistics in Korea, 1970 to 2010. Korean J Pediatr (2011) 54(11):429–35. doi: 10.3345/kjp.2011.54.11.429 - DOI - PMC - PubMed
    1. Seo SH. Low Fertility Trend in the Republic of Korea and the Problems of its Family and Demographic Policy Implementation. Population Economics (2019) 3(2):29–35. doi: 10.3897/popecon.3.e37938 - DOI
    1. Martin J, Hamilton B, Osterman M, Driscoll A. Births: Final Data for 2019. Natl Vital Stat Rep (2021) 70(2):1–51. doi: 10.15620/cdc:100472 - DOI - PubMed